Gut bacteria transplant for pulmonary arterial hypertension
Part of Lungs & breathing clinical trials.
This trial tests whether a special combination of antibiotics, fecal transplant (gut bacteria from healthy donors), and a fiber supplement can help people with pulmonary arterial hypertension (PAH). It aims to see if improving gut health can improve PAH symptoms and overall well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with pulmonary arterial hypertension (PAH) and are on a stable treatment plan for at least one month.
- You can swallow capsules and provide blood and stool samples.
- You are willing to follow the study schedule and can be contacted by phone, video, or in person.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have conditions like active inflammatory bowel disease, severe irritable bowel syndrome, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an inhaled medication (TPIP) that opens blood vessels in the lungs to help you breathe easier and be more active. It is for people with PAH who are already on stable treatment and have moderate symptoms.
This study tests whether using a mobile health tool can help people with pulmonary arterial hypertension (PAH) manage their condition in daily life. It’s aimed at adults who are stable on their PAH medicines and can track activity using a wearable device.
This study tests whether transplanting healthy gut bacteria can help people with moderate to severe alopecia areata regrow hair. You will take antibiotics to prepare your gut, then receive the transplant through a colonoscopy or capsules.
This trial tests whether transferring healthy gut bacteria (fecal microbiota transplant) can help people with chronic heart failure feel better and improve their heart function.
This trial tests whether a transplant of healthy gut bacteria (called a microbiome transplant) can slow down ALS in people whose disease is progressing rapidly. It aims to see if changing the gut environment can help with symptoms and quality of life.
This trial tests whether a stool transplant, which introduces healthy bacteria into the gut, can improve symptoms and quality of life in older adults with a type of heart failure where the heart's pumping function is preserved but filling is impaired. It may help because the gut bacteria can affect inflammation and heart health.
Hear when a new Pulmonary Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.